menu
    • menu

    Company profile for Jagsonpal

    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Together we can improve the quality of life

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Jagsonpal is among India’s premiere pharmaceutical companies. Jagsonpal has substantial research and development, manufacturing, marketing and distribution facilities. An impeccable track record of growth and profitability spanning over 5 decades, makes Jagsonpal an ideal company to partner with. Founded in 1964 the company specializes in developing and manufacturing bulk drugs and pharmaceutical formulations. Over the past...
    Jagsonpal is among India’s premiere pharmaceutical companies. Jagsonpal has substantial research and development, manufacturing, marketing and distribution facilities. An impeccable track record of growth and profitability spanning over 5 decades, makes Jagsonpal an ideal company to partner with. Founded in 1964 the company specializes in developing and manufacturing bulk drugs and pharmaceutical formulations. Over the past 50 years the firm has grown by leaps and bounds. The firm is committed to sustainable growth and is aggressively pursuing growth through market penetration, market expansion and multi-national expansion.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Jagsonpalindia-flag Flag
    Country
    Country
    India
    Address
    Address
    T-210 J, Shahpur Jat, New Delhi - 110 049
    Telephone
    Telephone
    011-46109900
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.jagsonpal.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    34th NZW-Hamburg

    Not Confirmed

    envelop Contact Supplier

    34th NZW-Hamburg

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Jagsonpal Pharmaceuticals Posts Q3 FY26 Profit At Rs. 10.95 Cr
    Jagsonpal Pharmaceuticals Posts Q3 FY26 Profit At Rs. 10.95 Cr

    24 Jan 2026

    // INDPHARMAPOST

    https://www.indianpharmapost.com/news/jagsonpal-pharmaceuticals-posts-q3-fy26-profit-at-rs-1095-cr-18969

    INDPHARMAPOST
    24 Jan 2026
    Share Share
    Jagsonpal Pharmaceuticals Q1 FY26 revenue up 23.1%
    Jagsonpal Pharmaceuticals Q1 FY26 revenue up 23.1%

    27 Jul 2025

    // INDPHARMAPOST

    https://www.indianpharmapost.com/news/jagsonpal-pharmaceuticals-q1-fy26-revenue-up-231-17484

    INDPHARMAPOST
    27 Jul 2025
    Share Share
    Jagsonpal Pharmaceuticals posts Q4 FY25 PAT at Rs. 6.58 Cr
    Jagsonpal Pharmaceuticals posts Q4 FY25 PAT at Rs. 6.58 Cr

    12 May 2025

    // INDPHARMAPOST

    https://www.indianpharmapost.com/news/jagsonpal-pharmaceuticals-posts-q4-fy25-pat-at-rs-658-cr-17135

    INDPHARMAPOST
    12 May 2025
    Share Share
    Jagsonpal Pharmaceuticals is on Health Canada Inspection List
    Jagsonpal Pharmaceuticals is on Health Canada Inspection List

    18 Mar 2025

    // HEALTH CANADA

    https://www.pharmacompass.com/pdf/news/jagsonpal-pharmaceuticals-is-on-health-canada-inspection-list-68376.pdf

    HEALTH CANADA
    18 Mar 2025
    Share Share
    FDA hits 2 Indian API makers with warning letters, import alerts
    FDA hits 2 Indian API makers with warning letters, import alerts

    21 Feb 2025

    // FIERCE PHARMA

    https://www.fiercepharma.com/manufacturing/fda-hits-pair-indian-api-drugmakers-warning-letters

    FIERCE PHARMA
    21 Feb 2025
    Share Share
    Jagsonpal Pharma Receives FDA Warning Letter
    Jagsonpal Pharma Receives FDA Warning Letter

    18 Feb 2025

    // FDA

    https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/jagsonpal-pharmaceuticals-limited-693134-02052025

    FDA
    18 Feb 2025
    Share Share

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Contact Jagsonpal and get a quotation

    Jagsonpal is a supplier offers 3 products (APIs, Excipients or Intermediates).

    Find a price of Dextrocarbinol bulk offered by Jagsonpal

    Find a price of Trimethoprim bulk offered by Jagsonpal

    Find a price of Tolnaftate bulk offered by Jagsonpal

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search